UNSPSC 51461602: Chondroitin/glucosamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HA000. This VA Drug Class (HA000) classifies this compound as belonging to the group HERBS/ALTERNATIVE THERAPIES.

UNSPSC 51461602 Chondroitin/glucosamine (Commodity) encompasses over-the-counter supplements and pharmaceutical-grade joint-health products that state and local government agencies purchase for distribution through health facilities, pharmacies, and employee wellness programs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions. The solicitation targets manufacturers capable of supplying chondroitin and glucosamine products with specific National Drug Codes (NDC), SKUs, and UPCs through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencara), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and carry comprehensive insurance including commercial general liability of $5 million per occurrence and network security and privacy liability of $2 million.

The cooperative purchasing model is the dominant sourcing channel visible in the recent record. MMCAP's RFP (S1070000015802), due March 26, 2026, prioritizes price competitiveness (weighted at 75 percent), with secondary emphasis on fixed pricing for the contract term (10 percent), compliance with administrative fee data format requirements (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). Products must be available in the marketplace by May 15, 2026, with awarded vendor agreements effective July 1, 2026 for a two-year term with optional extensions at MMCAP's discretion. The solicitation does not disclose specific award values or budget ranges. Vendors should expect performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials. Proposals must be submitted through the ePro procurement system using Google Chrome, with pricing and product information in designated Excel spreadsheet format converted to CSV and supporting documentation emailed to MMCAP_Infuse.RFP@state.mn.us.